Clinical analysis of HPV58-positive cervical cancer

Clinical analysis of HPV58-positive cervical cancer

Abstract Objective To study the clinical features of HPV58-positive cervical cancer. Methods A retrospective analysis of 347 patients with HPV58- or HPV16 positive cervical cancer from the Department of Gynecology Tumor of Guangxi Medical University Affiliated Cancer Hospital was performed. Molecula...

Full description

Bibliographic Details
Main Authors:	Mengjie Chen, He Wang, Yuejuan Liang, Li Li
Format:	Article
Language:	English
Published:	BMC 2020-06-01
Series:	Infectious Agents and Cancer
Subjects:	Human papilloma virus Cervical cancer Uterine corpus invasion Prognosis
Online Access:	http://link.springer.com/article/10.1186/s13027-020-00303-w

Similar Items

HPV-associated cervicitis
by: Margarita V. Andreeva, et al.
Published: (2023-01-01)

Knowledge regarding cervical cancer and HPV vaccine among medical students: A cross-sectional study
by: Jyoti Singh, et al.
Published: (2021-01-01)

Immunohistochemical characteristic of expression levels of Kі-67, p16INK4a, HPV16 in cervical intraepithelial neoplasia and cervical cancer
by: V. A. Tumanskiy, et al.
Published: (2017-08-01)

Cervical cytology and HPV in cervical cancer screening: Current and future perspectives
by: Pooja Bakshi, et al.
Published: (2023-01-01)

Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms
by: Emad Heydarnia, et al.
Published: (2024-02-01)

Human papilloma virus (HPV) infection and cervical lesions screened in 3 144 women at Xiamen, Fujian province, China
by: XU Hui-juan, LIU Kun, ZHENG Jing-mei, JIANG Qiu-li, LU Hua-dong, XU Jian-fang
Published: (2021-11-01)

Efficacy in Treatment of Cervical HrHPV Infection by Combination of Beta Interferon, and Herbal Therapy in Woman with Different Cervical Lesions
by: Ermina Iljazović, et al.
Published: (2008-11-01)

Level of Knowledge about Human Papillomavirus Infection among Women of Kashan City, Iran
by: Nekooi M.S. BSc, et al.
Published: (2016-03-01)

Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe
by: Stanie Gaete, et al.
Published: (2021-03-01)

CIN grades possessing different HPV RNA location patterns and RNAscope is helpful tool for distinguishing squamous intraepithelial lesions in difficult cervical cases
by: Ruichao Chen, et al.
Published: (2023-02-01)

Significance of survivin immunoreactivity and morphometric analysis of HPV-induced cervical dysplasia
by: Vukomanović-Đurđević Biserka, et al.
Published: (2014-01-01)

The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma
by: Zhimin He, et al.
Published: (2022-07-01)

The value of immunomodulatory therapy (use of vaginal suppositories) in treatment of HPV-associated neoplasia
by: I N Kononova, et al.
Published: (2014-10-01)

Detection of HPV Infection and the Current Status of Vaccine Research: A Review
by: Liuli Su, et al.
Published: (2023-03-01)

Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study
by: Wei-Chun Chen, et al.
Published: (2022-05-01)

Cytology May not be Sufficient for Cervical Screening in Women with HPV Types Other than Type 16-type 18
by: Erhan Okuyan, et al.
Published: (2023-03-01)

Incidence, trends and histopathological pattern of cervical malignancies at BP Koirala Memorial cancer hospital, Nepal.
by: TB Pathak, et al.
Published: (2013-03-01)

Antitumor immune cycle proteins and HPV status in patients with HSIL and cervical cancer
by: Elena V. Kayukova, et al.
Published: (2023-01-01)

EFFICACY OF VACCINE PREVENTION OF HPV-ASSOCIATED DISEASES AND CERVICAL CANCER IN THE MOSCOW REGION
by: V. I. Krasnopol'skiy, et al.
Published: (2016-02-01)

Features of HPV infection and screening characteristics of high-risk HPV negative in patients with cervical high-grade squamous intraepithelial lesion: a retrospective analysis of 459 cases
by: ZHANG Xiaolin, et al.
Published: (2022-02-01)

Relationship Between MicroRNA129-2 Expression and Cervical Cancer in Patients Infected with HPV
by: ZH Nazeri Givi, et al.
Published: (2018-02-01)

Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report
by: Alex Vorsters, et al.
Published: (2020-06-01)

HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa
by: Ruby Mcharo, et al.
Published: (2021-11-01)

Educación sobre cáncer cervicouterino en la adolescencia
by: María Antonieta González Bango, et al.

Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients
by: Lindsey A. Finch, et al.
Published: (2024-03-01)

Readability of online information about HPV Immunization
by: Sarah A. MacLean, et al.
Published: (2019-08-01)

Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
by: Xing Chen, et al.
Published: (2020-10-01)

Markers of Prognosis for Early Stage Cervical Cancer Patients (Stage IB1, IB2) Undergoing Surgical Treatment
by: Chen Xu, et al.
Published: (2021-06-01)

RISK FACTORS OF PRE-CANCER CERVICAL DISEASES IN WOMEN OF REPRODUCTIVE AGE
by: O.A. Dyndar, et al.
Published: (2020-02-01)

Association of Cervical Screening Results with Colposcopic Findings
by: Derya Kılıç, et al.
Published: (2020-09-01)

Knowledge of Chinese dentists on HPV, their willingness and barriers to recommend HPV vaccination to patients
by: Haoyue Xu, et al.
Published: (2021-08-01)

Results of the study of HPV-typing of anogenital area in patients with cervical intraepithelial neoplasia
by: L A Sulamanidze, et al.
Published: (2016-02-01)

Human papilloma viruses (HPV) and breast cancer – assessment of causality
by: James Sutherland Lawson, et al.
Published: (2016-09-01)

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
by: Baozhu Yi, et al.
Published: (2022-05-01)

CLINICAL FEATURES AND MANAGEMENT OF PATIENTS WITH DYSPLASIA OF CERVICAL EPITHELIUM ON THE BACKGROUND OF ABNORMAL MICROBIOCENOSIS OF VAGINA
by: V. V. Schaefer, et al.
Published: (2018-05-01)

Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma
by: Chae Moon Hong, et al.
Published: (2019-06-01)

A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide
by: Sumit Aggarwal, et al.
Published: (2024-02-01)

Innovative Diagnostic and Therapeutic Interventions in Cervical Dysplasia: A Systematic Review of Controlled Trials
by: Julia M. Hecken, et al.
Published: (2022-05-01)

The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status
by: Daniela Vargas-Robles, et al.
Published: (2023-08-01)

Effect of Chemotherapy and Surgery on System Immune Function of Patients with Cervical Cancer
by: CHEN Yu, et al.
Published: (2022-12-01)